Sign in
BVXV Stock Price, Chart, Stats & News
BiondVax Pharmaceuticals Ltd.
Save
4.97M
Market cap
–
Current P/E
–
Forward P/E
BVXV chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 90.84% |
ROA | -1.96% |
ROE | -4.92% |
D/E | -12.24x |
Interest coverage ratio | – |
BVXV valuation
P/E | – |
P/S | – |
P/B | -6.30x |
P/CF | -1.53x |
P/FCF | -1.93x |
P/OCF | -1.53x |
PEG | -0.07x |
EV multiple | -0.78x |
About
BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeutic products designed for the prevention and treatment of a range of infectious and other medical conditions. The company has established strategic licensing and collaboration agreements with prominent scientific institutions, notably the Max Planck Society and the University Medical Center Göttingen.
Similar securities
Based on sector and market capitalization
Report issue